Insulin Glargine
| Product Overview |
| Generic Name | Insulin Glargine |
| Brand Name(s) | Basalog |
| Form | Vial 5 mL |
| Strength | 100 IU/mL standard concentration |
| Therapeutic Class | Antidiabetic agent; long‑acting insulin analogue |
| ATC Code | A10AE04 |
| Manufacturing & Regulatory |
| Manufacturer | Biocon Biologics |
| Country | India |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Not publicly disclosed |
| COFEPRIS | Pending |
| Free Sale Certificate | Yes |
| Logistics & Export |
| MOQ | 100 units |
| Shelf Life | 24 months |
| Storage | Refrigerated (2–8 °C) |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation |
| Certificate of Analysis (COA) | Provided per batch |
| SDS | Upon Request |
| CTD Summary | Upon Request |
Description
Indications & Usage Once-daily basal insulin to improve glycemic control in adults and children (≥2 yrs) with type 1 or type 2 diabetes mellitus.
Request for Quote
